Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 26% ± 7% | |
epithelial cell | 4 studies | 26% ± 6% | |
astrocyte | 4 studies | 24% ± 5% | |
glutamatergic neuron | 4 studies | 34% ± 11% | |
GABAergic neuron | 3 studies | 33% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 17% ± 1% | |
basal cell | 3 studies | 22% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 93% | 304.90 | 2449 / 2642 | 64% | 2.74 | 449 / 705 |
bladder | 52% | 315.05 | 11 / 21 | 91% | 15.60 | 461 / 504 |
stomach | 61% | 221.47 | 219 / 359 | 81% | 7.99 | 232 / 286 |
esophagus | 40% | 531.16 | 583 / 1445 | 90% | 10.43 | 165 / 183 |
breast | 45% | 58.57 | 205 / 459 | 84% | 5.28 | 942 / 1118 |
prostate | 67% | 126.37 | 163 / 245 | 56% | 2.04 | 282 / 502 |
intestine | 35% | 258.18 | 337 / 966 | 84% | 9.57 | 442 / 527 |
skin | 92% | 753.91 | 1669 / 1809 | 12% | 0.44 | 55 / 472 |
lung | 15% | 19.57 | 85 / 578 | 89% | 9.91 | 1026 / 1155 |
pancreas | 3% | 2.91 | 9 / 328 | 93% | 15.10 | 166 / 178 |
tonsil | 0% | 0 | 0 / 0 | 93% | 20.40 | 42 / 45 |
uterus | 5% | 13.51 | 9 / 170 | 82% | 17.93 | 375 / 459 |
ovary | 1% | 1.00 | 2 / 180 | 75% | 4.28 | 324 / 430 |
kidney | 19% | 21.87 | 17 / 89 | 44% | 1.52 | 399 / 901 |
adipose | 41% | 54.75 | 493 / 1204 | 0% | 0 | 0 / 0 |
thymus | 12% | 12.64 | 80 / 653 | 27% | 0.82 | 166 / 605 |
liver | 1% | 3.47 | 3 / 226 | 9% | 0.51 | 37 / 406 |
adrenal gland | 3% | 3.19 | 8 / 258 | 4% | 0.15 | 9 / 230 |
heart | 4% | 9.27 | 38 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 3.11 | 14 / 803 | 0% | 0 | 0 / 0 |
spleen | 2% | 1.64 | 4 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
blood vessel | 1% | 3.18 | 15 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.22 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0005886 | Cellular component | plasma membrane |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | RHBDL2 |
Protein name | Rhomboid-related protein 2 (RRP2) (EC 3.4.21.105) (Rhomboid-like protein 2) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment (NTF); Rhomboid-related protein 2, C-terminal fragment (CTF)] |
Synonyms | |
Description | FUNCTION: Involved in regulated intramembrane proteolysis and the subsequent release of functional polypeptides from their membrane anchors. Known substrate: EFNB3. . |
Accessions | ENST00000540558.1 [Q9NX52-3] Q9NX52 ENST00000372990.6 [Q9NX52-1] ENST00000289248.6 [Q9NX52-1] |